Injury to axons and oligodendrocytes following endothelin-1-induced middle cerebral artery occlusion in conscious rats

Brain Research

Volumn 1110, Issue 1, 2006, Pages 13-22

  Gresle, Melissa M ^a   Jarrott, Bevyn ^a   Jones, Nicole M ^a   Callaway, Jennifer K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Axon; Cerebral ischemia; Endothelin 1; Oligodendrocyte; Stroke

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; ENDOTHELIN 1; PROTEIN SMI32; TAU 1 PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DENSITY; FOREBRAIN; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MEASUREMENT; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; CELL COUNT; DIFFUSE AXONAL INJURY; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROFILAMENT PROTEINS; OLIGODENDROGLIA; RATS; RATS, LONG-EVANS; TIME FACTORS;

ANIMALIA;

EID: 33748426170     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.06.111     Document Type: Article

References (52)

1. Bidmon H.J., Jancsik V., Schleicher A., Hagemann G., White O.W., Woodhams P., and Zilles K. Structural alterations and changes in cytoskeletal proteins and proteoglycans after focal cortical ischemia. Neuroscience 82 (1997) 397-420
2. Biernaskie J., Corbett D., Peeling J., Wells J., and Lei H. A serial study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats. Magn. Reson. Med. 46 (2001) 827-830
3. Bogaert L., Scheller D., Moonen J., Sarre S., Smolders I., Ebinger G., and Michotte Y. Neurochemical changes and laser Doppler flowmetry in the endothelin-1 rat model of focal cerebral ischemia. Brain Res. 887 (2000) 266-275
4. Bogousslavsky J., Van Melle G., and Regli F. The Lausanne stroke registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19 (1988) 1083-1092
5. Burke D., Bartley K., Woodforth I.J., Yakoubi A., and Stephen J.P.H. The effects of a volatile anaesthetic on the excitability of human corticospinal axons. Brain 123 (2000) 992-1000
6. Callaway J.K., Knight M.J., Watkins D.J., Beart P.M., and Jarrott B. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke 30 (1999) 2704-2712
7. Callaway J.K., Knight M.J., Watkins D.J., Beart P.M., Jarrott B., and Delaney P.M. A novel computerised method for quantitation of neuronal damage and its use to demonstrate neuroprotection by AM-36, a novel neuroprotective agent. J. Neurosci. Methods 102 (2000) 53-60
8. Dewar D., and Dawson D. Tau protein is altered by focal cerebral ischemia in the rat: an immunohistochemical and immunoblotting study. Brain Res. 684 (1995) 70-78
9. Dewar D., and Dawson D.A. Changes of cytoskeletal protein immunostaining in myelinated fibre tracts after focal cerebral ischaemia in the rat. Acta Neuropathol. (Berl.) 93 (1997) 71-77
10. Dewar D., Yam P., and McCulloch J. Drug development for stroke: importance of protecting cerebral white matter. Eur. J. Pharmacol. 375 (1999) 41-50
11. Dietrich W.D., Kraydieh S., Prado R., and Stagliano N.E. White matter alterations following thromboembolic stroke: a Beta-amyloid precursor protein immunocytochemical study in rats. Acta Neuropathol. (Berl.) 95 (1998) 524-531
12. Dittmar M., Spruss T., Schuierer G., and Horn M. External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats. Stroke 34 (2003) 2252-2257
13. Elsersy H., Sheng H., Lynch J.R., Moldovan M., Pearlstein R.D., and Warner D.S. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology 100 (2004) 1160-1166
14. Farkas E., Donka G., de Vos R.A.I., Mihaly A., Bari F., and Luiten P.G. Experimental cerebral hypoperfusion induces white matter and microglial activation in the rat brain. Acta Neuropathol. (Berl.) 108 (2004) 57-64
15. Farkas E., Annahazi A., Institoris A., Mihaly A., Luiten P.G., and Bari F. Diazoxide and dimethyl sulphoxide alleviate experimental hypoperfusion-induced white matter injury in the rat brain. Neurosci. Lett. 373 (2005) 195-199
16. Fern R., Waxman S.G., and Ransom B.R. Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA. J. Neurophysiol. 74 (1994) 369-377
17. Fern R., Waxman S.G., and Ransom B.R. Endogenous GABA attenuates CNS white matter dysfunction following anoxia. J. Neurosci. 15 (1995) 699-708
18. Gentleman S.M., Nash M.J., Sweeting C.J., Graham D.I., and Roberts D.J. β-Amyloid precursor protein (β-APP) as a marker for axonal injury after head injury. Neurosci. Lett. 169 (1993) 139-144
19. Hughes P.M., Anthony D.C., Ruuddin M., Botham M.S., Rankine E.L., Sablone M., Baumann D., Mir A.K., and Perry V.H. Focal lesions in the rat central nervous system induced by endothelin-1. J. Neuropathol. Exp. Neurol. 62 (2003) 1276-1286
20. Imai H., Masayasu H., Dewar D., Graham D.I., and Macrae I.M. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32 (2001) 2149-2154
21. Irving E.A., Yatsushiro K., McCulloch J., and Dewar D. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J. Cereb. Blood Flow Metab. 17 (1997) 612-622
22. Jackson S.J., Pryce G., Diemel L.T., Cuzner M.L., and Baker D. Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience 134 (2005) 261-268
23. Kalaria R.N., Bhatti S.U., Palatinsky E.A., Pennington D.H., Shelton E.R., Chan H.W., Perry G., and Lust W.D. Accumulation of the β amyloid precursor protein at sites of ischemic injury in rat brain. NeuroReport 4 (1993) 211-214
24. Katanoka K., Hayakawa T., Yamada K., Mushiroi T., Kuroda R., and Mogami H. Neuronal network disturbance after focal ischemia in rats. Stroke 20 (1989) 1226-1235
25. Leach M.J., Swan J.H., Eisenthal D., Dopson M., and Nobbs M. BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 24 (1993) 1063-1067
26. Li F., Omae T., and Fisher M. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats. Stroke 30 (1999) 2464-2471
27. 2+ channels, and GABAA receptors. Br. J. Anaesth. 90 (2003) 199-211
28. McCracken E., Fowler J.H., Dewar D., Morrison S., and McCulloch J. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist SPD 502. J. Cereb. Blood Flow Metab. 22 (2002) 1090-1097
29. McCracken E., Dewar D., and McCulloch J. Sipatrigine and oligodendrocyte and axonal pathology following transient focal cerebral ischemia in the rat. NeuroReport 14 (2003) 517-520
30. Meller D., Eysel U.T., and Schmidt-Kastner R. Transient immunohistochemical labeling of rat retinal axons during Wallerian degeneration by a monoclonal antibody to neurofilaments. Brain Res. 648 (1994) 162-166
31. Osbourne K.A., Shigeno T., Balarsky A.M., Ford I., McCulloch J., Teasdale G.M., and Graham D.I. Quantitative assessment of early brain damage in a rat model of focal cerebral ischemia. J. Neurol. Neurosurg. Psychiatry 50 (1987) 402-410
32. Otsuka N., Tomonaga M., and Ikeda K. Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 568 (1991) 335-338
33. Ouyang W., Wang G., and Hemmings H.C. Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals. Mol. Pharmacol. 64 (2003) 373-381
34. Ozden S., and Isenmann S. Neuroprotective properties of different anesthetics on axotomized rat retinal ganglion cells in vivo. J. Neurotrauma 21 (2004) 73-82
35. Pantoni L., Garcia J.H., and Guitierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 27 (1996) 1641-1647
36. Parish C.L., Finkelstein D.I., Drago J., Borrelli E., and Horne M.K. The role of dopamine receptors in regulating the size of axonal arbors. J. Neurosci. 21 (2001) 5147-5157
37. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
38. Rabb C.H. Nylon monofilament for intraluminal middle cerebral artery occlusion in rats (letter). Stroke 27 (1996) 151
39. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., and Hanns-Jeurgen R. A critical re-evaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-doppler flowmetry. Stroke 29 (1998) 2162-2170
40. Sharkey J., Ritchie I.M., and Kelly P.A.T. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 13 (1993) 865-871
41. Stanic D., Tripanichkul W., Drago J., Finkelstein D.I., and Horne M.K. Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra. Brain Res. 1023 (2004) 83-91
42. Sternberger L.A., and Sternberger N.H. Monoclonal antibodies distinguish phosphorylated and non-phosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 6126-6130
43. 2+ exchanger. J. Neurosci. 12 (1992) 430-439
44. Takamatsu H., Kondo K., Ikeda Y., and Umemura K. Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion. Eur. J. Pharmacol. 362 (1998) 137-142
45. Takizawa S., Fukuyama N., Hirabayashi H., Kohara S., Kazahari S., Shinohara Y., and Nakazawa H. Quercetin, a natural flavinoid, attenuates vacuolar formation in the optic tract in rat chronic cerebral hypoperfusion model. Brain Res. 980 (2003) 156-160
46. Tsuchiya M., Sako K., Yura S., and Yonemasu Y. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp. Brain Res. 89 (1992) 87-92
47. Valeriani V., Dewar D., and McCulloch J. Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: attenuation of damage after transient ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 765-771
48. Wakita H., Tomimoto H., Akiguchi I., Lin J., Ihara M., and McGeer P.L. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res. 924 (2002) 63-70
49. Wakita H., Tomimoto H., Akiguchi I., Lin J., Ihara M., Ohtani R., and Shibata M. Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. Brain Res. 992 (2003) 53-59
50. Yam P.S., Takasago T., Dewar D., Graham D.I., and McCulloch J. Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion. Brain Res. 760 (1997) 150-157
51. Yam P.S., Dunn L.T., Graham D.I., Dewar D., and McCulloch J. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 772-779
52. Yaqub B.A., Shamena A.R., Kolawole T.M., and Patel P.J. Cerebrovascular disease in Saudi Arabia. Stroke 22 (1991) 1173-1176